Hainan Haiyao Co., Ltd. (SHE:000566)
China · Delayed Price · Currency is CNY 5.18
+0.16 (3.19%)
Aug 20, 2026, 3:04 PM CST
Hainan Haiyao Revenue
Hainan Haiyao had revenue of 168.18M CNY in the quarter ending March 31, 2026, a decrease of -18.60%. This brings the company's revenue in the last twelve months to 792.76M, down -4.98% year-over-year. In the year 2025, Hainan Haiyao had annual revenue of 831.18M, down -16.10%.
Revenue (ttm)
792.76M
Revenue Growth
-4.98%
P/S Ratio
8.48
Revenue / Employee
456.14K
Employees
1,738
Market Cap
6.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 831.18M | -159.52M | -16.10% |
| Dec 31, 2024 | 990.70M | -487.88M | -33.00% |
| Dec 31, 2023 | 1.48B | -300.47M | -16.89% |
| Jan 1, 2023 | 1.78B | -280.01M | -13.60% |
| Jan 1, 2022 | 2.06B | -141.25M | -6.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.64B |
| China Animal Husbandry Industry | 6.45B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Cisen Pharmaceutical | 3.37B |
| Jiangsu Kanion Pharmaceutical | 3.25B |
| Tianjin Tianyao Pharmaceuticals | 2.73B |
| Guangxi Wuzhou Zhongheng Group | 1.58B |
| Bide Pharmatech | 1.35B |